Announcements Trials

Browse Landscape

Phase

Phase 2 5 Phase NA 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 28 Colorectal Neoplasms 13 Colonic Neoplasms 13 Rectal Neoplasms 9 Prostatic Neoplasms 7 Head and Neck Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Uterine Cervical Neoplasms 5 Stomach Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Sarcoma 5 Melanoma 5 Endometrial Neoplasms 5 Central Nervous System Neoplasms 5 Ovarian Neoplasms 4 Neoplasm Metastasis 4 Lung Neoplasms 4 Kidney Neoplasms 4 Esophageal Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Pancreatic Neoplasms 3 Neuroblastoma 3 Liver Neoplasms 3 Liposarcoma 3 Hemangiosarcoma 3 Hemangiopericytoma, Malignant 3 Gallbladder Neoplasms 3 Fibrosarcoma 3 Esophageal Squamous Cell Carcinoma 3 Carcinoma, Hepatocellular 3

Interventions

exemestane 4 Tamoxifen 3 Paclitaxel 3 Letrozole 3 Goserelin 3 Cyclophosphamide 3 pegfilgrastim 2 Radiotherapy 2 Pyridoxine 2 Leuprolide 2 Fluorouracil 2 Epirubicin 2 Capecitabine 2 Bevacizumab 2 Anastrozole 2 trastuzumab biosimilar HLX02 1 ribociclib 1 elacestrant 1 Zoledronic Acid 1 Trastuzumab 1 Taxes 1 Radiosurgery 1 Prochlorperazine 1 Palonosetron 1 PF-05280014 1 Ontruzant 1 Ogivri 1 Neoadjuvant Therapy 1 Mometasone Furoate 1 Methotrexate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Breast Neoplasms, Male × Chemotherapy, Adjuvant × Clear all

NCT00301925 2018-08-08

TACT2

Institute of Cancer Research, United Kingdom

Phase 3 Unknown

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon ⚡